BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

Similar documents
Newborn Screening: Focus on Treatment

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

CHRONIC MYELOGENOUS LEUKEMIA

For Your Baby s Health Department of Health

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Further expansion of the neonatal screening panel in the Netherlands

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Centres of reference for rare diseases expectations based on Polish experience. Małgorzata Krajewska-Walasek

Positive Newborn Screens: What do you do next?

State of the Art of Rare Disease Activities in EU Member States and Other European Countries. Slovak Republic Report

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

Activities in the field of rare diseases in Slovakia. CISARIK František Faculty Hospital Žilina

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

Should Universal Carrier Screening be Universal?

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Rare Disease Day Brussels, 1 March

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

A Guide for Prenatal Educators

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN

All diseases on Foresight

Inborn Errors of Metabolism (IEM)

Newborn Bloodspot Screening Information for parents

Topeka Indiana LaGrange/ Elkhart Counties Indiana Plain Church Population over 46,000

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Newborn Screening: Blood Spot Disorders

Integrating the Latest in Genomic Science into Modern Medical Practice

Newborn Bloodspot Screening Information for parents

NEWBORN METABOLIC SCREEN, MINNESOTA

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

PREDICAGEN LLC REPORT

Newborn Screening in Manitoba. Information for Health Care Providers

Considerations in Choosing Screening Conditions: One (US) Approach

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

ICD-10 Physician Education. Medical Genetics

Neonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012

Genetic Diseases. SCPA202: Basic Pathology

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

Evaluation of the Hypotonic Infant and Child

GUIDE TO NEWBORN SCREENING PROGRAMME

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

Newborn bloodspot testing

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Health and Wellness for all Arizonans. azdhs.gov

PATIENT EDUCATION. carrier screening INFORMATION

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

General Approach to Genetic Testing

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Portugal Report

Medical Policy Preimplantation Genetic Testing

Executive summary. Criteria for inclusion in the screening programme

SUMMARY COMPARISON OF NATIONAL PLANS AND PRACTICES. Domenica Taruscio

For the Ongoing Management of Babies under 1 year old.

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Expanded Carrier Screening: What s Best?

2015 Annual Report for New Mexico s Newborn Screening (NBS) Program

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Introduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.

Medical Foods for Inborn Errors of Metabolism

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Proposal for EXPANDED NEWBORN SCREENING

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

The Floppy Baby. Clare Betteridge

Gaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance

Neonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP

Newborn Screening in Washington State Saving lives with a simple blood spot

Inborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

Newborn Screening: What s New?

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

MEDICAL GENETICS CLINICAL CARE ROTATION

Carrier Screening: How to be tested

General Approach to Genetic Testing

CLINICAL AND HUMAN TESTING

UK Newborn Screening for X-ALD - progress from a lab perspective

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN

M-N. Neisseria gonorrhoeae. Neopterin, Serum. Analytik

Utility of Microarrays in Molecular Genetics

CLINICAL GENETICS 1. GENERAL ASPECTS OF THE SPECIALISATION. 1.1 Purpose of the specialisation

Identifying Needs, Implementing Services in the Indiana Plain Community

Human Genetic Diseases (Ch. 15)

Information for health professionals

A Brief History of Newborn Screening

PRE-PREGNANCY CARRIER SCREENING. What is it, how does it work and should future parents consider it?

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

What s New in Newborn Screening?

The Many Lives of the Newborn Screening Dried Blood Spot (the LIFE CYCLE of a Blood Spot)

NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM OUR EXPERIENCE AT CABRI, GULF MEDICAL UNIVERSITY

E-IMD European registry and network for intoxication type metabolic diseases

Testing Strategy for Inborn Errors of Metabolism in the Neonate Aditi I. Dagli, Roberto T. Zori and Bryce A. Heese. DOI: /neo.

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital

Foresight Carrier Screen

Transcription:

BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

Strategy for rare diseases in Bulgaria Project of National Program for Rare Diseases 2007 2011 November 2006 March 2008 the Healthcar re Committee at the Bulgarian National Assembly started discussion on issues concerning prevention, diagnosis, treatment and rehabilitation of people with rare diseases in Bulgaria September 2008 Mr. E. Zhelev, Minister of Health, has approved the National Programme for Rare Diseases (2009 2013)

National program for rare diseases 2009 2013 (genetic, birth defects and non inherited diseases) To create an adequate institutional framework and mechanisms, ensuring timely prevention, diagnosis, optimal treatment and rehabilitation of patients with rare diseases (genetic, birth defects and non inherited diseases) in Bulgaria. Patient associations Awareness Integrationn Research Medical training Neonatal screening Genetic services Epidemiological surveillance EU collaboration Budget: 11.3 M???

Program Activities 1. Establishment of a National Consulting Council for Rare Diseases (NCCRD) within the Ministry of Health

Program Activities 2. Establishment of expert panels for rare diseases working with the national consultants The main task is to propose to NCCRD a list of actual for Bulgaria rare dis seases within the scope of their corresponding medical specialty. Status still working on!!!

Program Activities 3. Establishment of a national network of information reference centres for rare diseases

Program Activities 4. Establishment of a national register of patients with rare diseases Status still working on!!!

NATIONAL ALLIANCE OF PEOPLE WITH RARE DISEASES NATIONAL ASSOCIATION OF GAUCHER DISEASE CORNELIA DE LANGE SYNDROME ASSOCIATION ASSOCIATION OF LYMPHOMA PATIENTS ASSOCIATION EPIDERMOLYSISS BULLOSA BULGARIA BULGARIAN ANTI THALASSAEM MIA ORGANISATION ORGANISATION OF THALASSAEMIA PATIENTS IN BULGARIA BULGARIAN ASSOCIATION FOR NEUROMUSCULAR DISEASES NATIONAL ASSOCIATION OF PEOPLE SUFFERING FROM CHRONIC MYELOGENOUS LEUKEMIA BULGARIAN ASSOCIATION PRADER WILLI SYNDROME BULGARIAN CYSTIC FIBROSIS ASSOCIATION BULGARIAN ASSOCIATION WILSON'S DISEASE

Program Activities 5. Improvement of the prevention and diagnostics of rare genetic diseases, predispositions, and congenital anomalies (PKU, CHT, 21 hydroxylase deficiency) 6. Improved treatment control of genetic and congenital diseases Introducing of mass neo onatal screening for 21 hydroxylase deficiency Promotion and Enlargment of Biochemical Screening for most common aneuploidies Introducing of genetic test for mental retardation, several monogenic disorders Introducing of methods for clarifying the carrier status in families with DMD, and SMA

List of disorders PKU Hyperphenylalaninemia Tyrosinemia I Tyrosinemia II MSUD Nonketotic hyperglycinemia Citrullinemia (ASS) Argininemia (ARG1) Alkaptonuria Methylmalonic acidemia Propionic acidemia Holocarboxilase synt. def. MLYCD Malonyl CoA decarboxilase def. Isovaleric acidemia (IVA) 3M crotonyl CoA Carboxilase def. (MCCC1) 3 M glutaconyl CoA hydratase def. (MGA3) III 3 OH 3 M Glutaric aciduria (HMGCL) Mevalonic aciduria (MVK) Dihydropyrimidine deficiency (DPD) Orotic aciduria 5 Oxoprolinuria Glutaric aciduria I (GAI) 2 OH Glutaric aciduria Glyceroluria (GK1) D Glyceric aciduria (D glycerate kinase deficiency) Fumarase def. (FH) Canavan 4 OH butyric aciduria (SSADH) MCAD SCAD LCAD LCHAD MADD (glutaric aciduria II) X ALD Lipoamide dehydrogenase defficiency (Е3) Galactosemia, classic Galactokinase deficiency G6PD deficincy GM1

List of disorders Orotic aciduria 5 Oxoprolinuria Glutaric aciduria I (GAI) 2 OH Glutaric aciduria Glyceroluria (GK1) D Glyceric aciduria (D glycerate kinase deficiency) Fumarase def. (FH) Canavan 4 OH butyric aciduria (SSADH) MCAD SCAD LCAD LCHAD MADDD (glutaric aciduria II) X ALD Lipoamide dehydrogenase defficiency (Е3) Galactosemia, classic Galactokinase deficiency G6PD deficincy GM1 Orotic aciduria 5 Oxo oprolinuria Glutaric aciduria I (GAI) 2 OH Glutaric aciduria Glyceroluria (GK1) D Glyceric aciduria (D glycerate kinase deficiency) Fumarase def. (FH)

List of disorders alpha 1 antitrypsine deficiency CCFDN GEFS+ Congenital myasthenia epsilon disease DMD BMD XLD LMD2A CMT 1A CMT 1B CMT 1F/2E CMTX1 CMT 2A: CMT 2A2, CMT 2A1 CMT 2D DI CMTC Spinal muscular atrophy type I (SMA 1) Spinal muscular atrophy type II (SMA 2) Spinal muscular atrophy type III (SMA 3) Beta thalassemia Cystic fibrosis Hemophilia A Dilatative cardiomyopathy (CMD1A), lamin A/C Familial partial lipodystrophy (FPLD), lamin A/C Mandibuloacral dysplasia (MAD), lamin A/C Hutchinson Gilford progeria syndrome (HGPS), lamin A/C Werner's syndrome (WS), lamin A/C Restrictive dermopathy (RD), lamin A/C Ken nedy disease CCFN CMS Niemann Pick disease MCAD HMSNL Smith Lemli Opitz syndrome Myotonic dystrophy 1 Steinert Disease Myotonic dystrophy 2 PROMM MUSCULAR DYSTROPHY, CONGENITAL MEROSIN DEFICIENT, 1A; MDC1A Huntington chorea, huntingtin

Program Activities 7. Improved communication among the medical genetic consulting offices throughout the country 8. Improved genetic and screening network structure in the country Internet based usag ge of software for risk calculation between the centers providing Biochemical Screening for aneupolidies Internet access to the results from Biochemical Screening for the patients.

Program Activities 9. Increase of the awareness, knowledge and professional qualification of the medical professionals. Meeting of the neonatologist for education in early diagnosis of ly ysosomal storage disorders in neonatal period Meeting of pediatricians for education in early diagnosis growth hormone deficiency in children

Program Activities Equal access to diagnostics and prevention in minority populations

Roma population Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet. 1996 Oct;14(2):214 7. Congenital cataracts facial dysmorphism neuropathy syndrome, a novel complex genetic disease in Balkan Gypsies: clinical and electrophysiological observations. Ann Ne eurol. 1999 Jun;45(6):742 50.

Roma population Equal access to diagnostics and prevention OMIM ID 605285 A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. Am J Hum Genet. 2000 Sep;67(3):664 71. Epub 2000 Jul 27.

Program Activities Prenatal diagnosis s 1900 for 2010 50 diagnosed eneuploidies 8 risk pregnancies for monogenic disorders

"You got to make good out of bad "That's alll there is to make it with." Robert Penn Warren